Navigation Links
Late-stage melanoma results in economic burden

In an article published in the March 2010 Archives of Dermatology, researchers report that in the United States, melanoma treatment in late stages of the disease is of significant cost in the population 65 years and older.

The incidence of melanoma has risen dramatically over the years, and older white men have the highest rate of mortality. Epidemiologists say that one in 49 men and one in 73 women are affected in a lifetime, in contrast to one in 1,500 persons in the 1930s. The American Cancer Society reports that melanoma is the sixth most commonly diagnosed cancer in the United States.

"We already know the more quickly melanoma can be detected and treated, the lower the mortality rate," says Suephy C. Chen, MD, MS, assistant professor in the Department of Dermatology at Emory University School of Medicine, and principal investigator of the study.

"The data from this study help show that early detection is also very important in decreasing the economic burden from melanoma, especially in the older population."

The researchers gathered data from the Surveillance, Epidemiology and End Results (SEER)Medicare-linked population-based database for fiscal years 1991-1996 of persons 65 years or older who had late-stage melanoma. Their findings showed that average monthly, per-patient melanoma charges were $2,194 during the initial four months of treatment; dropped to $902 during the interim phase; but increased to $3,933 during the terminal six months of treatment.

The study authors concluded from the data that if all patients were diagnosed and treated in stage 0 or 1, the annual direct costs for the population 65 years or older would be between $99 million and $16 million 40-65 percent of the current costs of $249 million.

"The US population is aging rapidly," explains Chen. Routine screening of these individuals to diagnose melanoma before it reaches an advanced stage will not only impact the physical outcome, but could also vastly reduce the financial burden of the disease."


Contact: Kathi Baker
Emory University

Related medicine news :

1. Tulane Cancer Center to begin novel clinical trial for late-stage prostate cancer drug
2. Genes signal late-stage laryngeal cancer, poorer outcome
3. Surgery not necessary for most late-stage colorectal cancers
4. City-dwellers have higher risk of late-stage cancer than rural residents
5. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
6. Bone Cement Eases Pain of Late-Stage Cancers
7. CTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
8. Broccoli compound targets key enzyme in late-stage cancer
9. Patients own infection-fighting T cells put late-stage melanoma into long-term remission
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. Drug Helps Fight Late-Stage Colon Cancer in Some Patients
Post Your Comments:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: